Pharmacological Agents for the Treatment of Skin and Soft Tissue Infections: What is the Role for Daptomycin?

Theodoros Kelesidis

JOURNAL

Clinical Medicine Reviews in Therapeutics

Pharmacological Agents for the Treatment of Skin and Soft Tissue Infections: What is the Role for Daptomycin?

Submit a Paper

Theodoros Kelesidis

Clinical Medicine Reviews in Therapeutics 2014:6 7-12

Review

Published on 31 Mar 2014

DOI: 10.4137/CMRT.S9283

Further metadata provided in PDF

Sign up for email alerts to receive notifications of new articles published in Clinical Medicine Reviews in Therapeutics

Abstract and Sharing
Article Metrics
Discuss

Abstract

Skin and soft tissue infections (SSTIs) have increasing prevalence in clinical practice. The emergence of resistant pathogens and especially methicillin-resistant Staphylococcus aureus (MRSA) has led to an increase in the number of hospitalizations due to SSTIs. Daptomycin has been shown to achieve good concentrations in skin and soft tissues and is effective and safe for the treatment of SSTIs. In this review, I summarize the scientific evidence regarding the role of daptomycin in therapy of SSTIs, comparing daptomycin with other antimicrobial agents.

Downloads

RIS citation (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation (BIBDESK, LATEX)

What Your Colleagues Say About Libertas Academica

Bioinformatics and Biology Insights fills a gap in current journals. Ever more often, bioinformatics and detailed analysis of data creates novel, unexpected insights. It is good to have a journal which focusses on exactly this aspect of bioinformatics research, putting the biology insights upfront with high respect for the different methods in bioinformatics.

Dr Thomas Dandekar (University of Wurzburg, European Molecular Biology Laboratory, Heidelberg, Germany)

More Testimonials